Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-β2 expression via DNA methylation

Journal of General Virology

Volumn 91, Issue 2, 2010, Pages 493-500

  Jung, Jin Kyu ^a   Park, Sun Hye ^a   Jang, Kyung Lib ^a  

^a Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; HEPATITIS B VIRUS X PROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P27; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA2; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR, BETA2, HUMAN; TRANSACTIVATOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA CELL; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; CELL PROLIFERATION; DRUG EFFECT; GENETICS; LIVER TUMOR; METABOLISM; PATHOPHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; RECEPTORS, RETINOIC ACID; TRANS-ACTIVATORS; TRETINOIN;

EID: 76249128584     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.015149-0     Document Type: Article

References (49)

1. Benn, J., Su, F., Doria, M. & Schneider, R. J. (1996). Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 70, 4978-4985.
2. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J 10, 940-954.
3. De Luca, L. M. (1991). Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 5, 2924-2933.
4. Dietze, E. C., Caldwell, L. E., Marcom, K., Collins, S. J., Yee, L., Swisshelm, K., Hobbs, K. B., Bean, G. R. & Seewaldt, V. L. (2002). Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300. Microsc Res Tech 59, 23-40.
5. Gebert, J. F., Moghal, N., Frangioni, J. V., Sugarbaker, D. J. & Neel, B. G. (1991). High frequency of retinoic acid receptor beta abnormalities in human lung cancer. Oncogene 6, 1859-1868.
6. Hansen, L. A., Sigman, C. C., Andreola, F., Ross, S. A., Kelloff, G. J. & De Luca, L. M. (2000). Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 21, 1271-1279.
7. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D. & Baylin, S. B. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93, 9821-9826.
8. Hoffman, A. D., Engelstein, D., Bogenrieder, T., Papandreou, C. N., Steckelman, E., Dave, A., Motzer, R. J., Dmitrovsky, E., Albino, A. P. & Nanus, D. M. (1996). Expression of retinoic acid receptor β in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. Clin Cancer Res 2, 1077-1080.
9. Houle, B., Rochette-Egly, C. & Bradley, W. E. (1993). Tumor suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc Natl Acad Sci U S A 90, 985-989.
10. Hu, L., Crowe, D. L., Rheinwald, J. G., Chambon, P. & Gudas, L. J. (1991). Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 51, 3972-3981.
11. Jung, J. K., Arora, P., Pagano, J. S. & Jang, K. L. (2007). Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res 67, 5771-5778.
12. Kim, C. M., Koike, K., Saito, I., Miyamura, T. & Jay, G. (1991). HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351, 317-320.
13. Kim, G. D., Ni, J., Kelesoglu, N., Roberts, R. J. & Pradhan, S. (2002). Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J 21, 4183-4195.
14. Kwun, H. J. & Jang, K. L. (2004). Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res 32, 2202-2213.
15. Lee, Y. H. & Yun, Y. (1998). HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 273, 25510-25515.
16. Lee, S., Lee, H. J., Kim, J. H., Lee, H. S., Jang, J. J. & Kang, G. H. (2003). Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163, 1371-1378.
17. Lee, J. O., Kwun, H. J., Jung, J. K., Choi, K. H., Min, D. S. & Jang, K. L. (2005). Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24, 6617-6625.
18. Liu, Y., Lee, M. O., Wang, H. G., Li, Y., Hashimoto, Y., Klaus, M., Reed, J. C. & Zhang, X. (1996a). Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16, 1138-1149.
19. Liu, M., Iavarone, A. & Freedman, L. P. (1996b). Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271, 31723-31728.
20. Lotan, R. (1995). Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J Natl Cancer Inst 87, 1655-1657.
21. Maguire, H. F., Hoeffler, J. P. & Siddiqui, A. (1991). HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252, 842-844.
22. Matsushima-Nishiwaki, R., Okuno, M., Adachi, S., Sano, T., Akita, K., Moriwaki, H., Friedman, S. L. & Kojima, S. (2001). Phosphorylation of retinoid X receptor α at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res 61, 7675-7682.
23. Murphree, A. L.. & Benedict, W. F. (1984). Retinoblastoma: clues to human oncogenesis. Science 223, 1028-1033.
24. Palii, S. S. & Robertson, K. D. (2007). Epigenetic control of tumor suppression. Crit Rev Eukaryot Gene Expr 17, 295-316.
25. Park, S. G., Chung, C., Kang, H., Kim, J. Y. & Jung, G. (2006). Upregulation of cyclin D1 by HBx is mediated by NF-κB2 /BCL3 complex through κB site of cyclin D1 promoter. J Biol Chem 281, 31770-31777.
26. Park, I. Y., Sohn, B. H., Yu, E., Suh, D. J., Chung, Y. H., Lee, J. H., Surzycki, S. J. & Lee, Y. I. (2007). Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132, 1476-1494.
27. Paterlini, P., Poussin, K., Kew, M., Franco, D. & Brechot, C. (1995). Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21, 313-321.
28. Qadri, I., Maguire, H. F. & Siddiqui, A. (1995). Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci U S A 92, 1003-1007.
29. Ren, M., Pozzi, S., Bistulfi, G., Somenzi, G., Rossetti, S. & Sacchi, N. (2005). Impaired retinoic acid (RA) signal leads to RARβ2 epigenetic silencing and RA resistance. Mol Cell Biol 25, 10591-10603.
30. Robert, M. F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A. & MacLeod, A. R. (2003). DNMT 1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33, 61-65.
31. Saito, Y., Kanai, Y., Nakagawa, T., Sakamoto, M., Saito, H., Ishii, H. & Hirohashi, S. (2003). Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 105, 527-532.
32. Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S. J. & Swisshelm, K. (1995). Expression of retinoic acid receptor mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 6, 1077-1088.
33. 2 expression via DNA methylation. Cancer Lett 270, 66-76.
34. Shih, W. L., Kuo, M. L., Chuang, S. E., Cheng, A. L. & Doong, S. L. (2000). Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem 275, 25858-25864.
35. 2 mediated growth inhibition in HeLa cells. Exp Cell Res 223, 102-111.
36. Slagle, B. L., Lee, T. H., Medina, D., Finegold, M. J. & Butel, J. S. (1996). Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 15, 261-269.
37. Soprano, K. J., Purev, E., Vuocolo, S. & Soprano, D. R. (2006). Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid. Oncogene 25, 5315-5325.
38. Sun, S. Y., Wan, H., Yue, P., Hong, W. K. & Lotan, R. (2000). Evidence that retinoic acid receptor β induction by retinoids is important for tumor cell growth inhibition. J Biol Chem 275, 17149-17153.
39. Tang, H., Oishi, N., Kaneko, S. & Murakami, S. (2006). Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci 97, 977-983.
40. Terradillos, O., Billet, O., Renard, C. A., Levy, R., Molina, T., Briand, P. & Buendia, M. A. (1997). The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14, 395-404.
41. Ting, A. H., Jair, K. W., Suzuki, H., Yen, R. W., Baylin, S. B. & Schuebel, K. E. (2004). CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Nat Genet 36, 582-584.
42. Tischoff, I. & Tannapfe, A. (2008). DNA methylation in hepatocellular carcinoma. World J Gastroenterol 14, 1741-1748.
43. Tsai, C. N., Tsai, C. L., Tse, K. P., Chang, H. Y. & Chang, Y. S. (2002). The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A 99, 10084-10089.
44. Wang, A., Zeng, R. & Huang, H. (2008). Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells. Oncol Res 17, 175-182.
45. Xu, X. C. (2007). Tumor-suppressive activity of retinoic acid receptor-β in cancer. Cancer Lett 253, 14-24.
46. Xu, X. C., Ro, J. Y., Lee, J. S., Shin, D. M., Hong, W. K. & Lotan, R. (1994). Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54, 3580-3587.
47. Yang, B., Guo, M., Herman, J. G. & Clark, D. P. (2003). Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163, 1101-1107.
48. Kip1 up-regulation is a relevant early event. Oncogene 17, 1827-1836.
49. Zheng, D. L., Zhang, L., Cheng, N., Xu, X., Deng, Q., Teng, X. M., Wang, K. S., Zhang, X., Huang, J. & Han, Z. G. (2009). Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol 50, 377-387.